학술논문
Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)
Document Type
Article
Author
Coleman, R.E.; Collinson, M.; Gregory, W.; Marshall, H.; Bell, R.; Dodwell, D.; Keane, M.; Gil, M.; Barrett-Lee, P.; Ritchie, D.; Bowman, A.; Liversedge, V.; De Boer, R.H.; Passos-Coelho, J.L.; O'Reilly, S.; Bertelli, G.; Joffe, J.; Brown, J.E.; Wilson, C.; Tercero, J.C.; Jean-Mairet, J.; Gomis, R.; Cameron, D.
Source
In Journal of Bone Oncology November 2018 13:123-135
Subject
Language
ISSN
2212-1374